Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials

OBJECTIVE: Clinical trials are increasingly globalized, and adverse event (AE) rates and treatment responses may differ by geographical region. This study assessed regional differences in AE reporting rates and ACR response rates (ACR20/50) in patients with RA who received placebo/standard-of-care t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Rheumatology (Oxford)
Autores principales: Keebler, Daniel, Teng, Edmond, Chia, Jenny, Galanter, Joshua, Peake, Jodie, Tuckwell, Katie
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7516100/
https://ncbi.nlm.nih.gov/pubmed/32182362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa043
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares